Evidence map›Paper›PMID 9710436›Full record

ArticleThe Journal of clinical investigation1998

Immunoglobulin kappa chain receptor editing in systemic lupus erythematosus.

T Dörner, S J Foster, N L Farner, P E Lipsky

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in The Journal of clinical investigation, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 109 citations in OpenAlex.

  1. Trial
  2. B cell tolerance and autoimmunity: Lessons from repertoires.The Journal of experimental medicine · 2024
    Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. [Therapy-resistant cells of the B cell line].Zeitschrift fur Rheumatologie · 2016
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Mechanisms of B cell autoimmunity in SLE.Arthritis research & therapy · 2011
    Review
  15. B cell receptor editing in tolerance and autoimmunity.Annals of the New York Academy of Sciences · 2011
    Review
  16. [From stem cells to lymphocytes].Zeitschrift fur Rheumatologie · 2009
    Review
  17. Article
  18. Article
  19. Reduced receptor editing in lupus-prone MRL/lpr mice.The Journal of experimental medicine · 2007
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

T DörnerDepartment of Internal Medicine and Harold C. Simmons Arthritis Research Center, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75235, USA.
S J Foster
N L Farner
P E Lipsky
The University of Texas Southwestern Medical Center · US

Funding

ROLE OF CD40 LIGAND IN LYMPHOCYTE ACTIVATION, DEVELOPMENT, AND DIFFERENTIATIONP01AI031229 · NIAID · YESHIVA UNIVERSITY · PI DIAMOND, BETTY · 1991 to 2001
$1.6M
NIAID NIH HHS AI 31229
6 · The paper itself

Abstract

To determine whether receptor editing of Vkappa genes was involved in the pathogenesis of systemic lupus erythematosus (SLE), the usage of Vkappa and Jkappa gene elements from individual peripheral CD19(+) B cells obtained from a patient with untreated SLE was examined. No differences in the Vkappa and Jkappa gene usage in the nonproductive gene repertoire of this SLE patient were noted compared with the distribution of genes found in normal adults. However, an increased usage of Jkappa5 segments, and a significant overrepresentation of the Vkappa1 and Vkappa4 families, especially the L15, O14/O4, and B3 genes characterized the productive Vkappa gene repertoire of the SLE patient. Furthermore, Jkappa5-containing Vkappa gene rearrangements in the productive but not the nonproductive repertoire manifested significantly fewer mutations compared with Vkappa genes recombined with Jkappa1-4. These data are consistent with the conclusion that receptor editing of Vkappa is much more apparent in this SLE patient than in normals and suggest that a deficiency in this means to counteract the emergence of autoimmunity is not an essential feature of SLE.

Indexed as

Gene Rearrangement, B-LymphocyteDNA Mutational AnalysisHumansImmunoglobulin Joining RegionImmunoglobulin kappa-ChainsImmunoglobulin Variable RegionInfant, NewbornLupus Erythematosus, SystemicMiddle AgedMolecular Sequence DataImmunoglobulin Joining RegionImmunoglobulin kappa-ChainsImmunoglobulin Variable Region

Identifiers

PMID9710436
PMCPMC508930
OpenAlexW2170142229

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.